The Celgene Merger Looks Secure — So Why Is Bristol Under Pressure?Investors Business Daily • 06/05/19
Bristol-Myers Squibb And AbbVie: Pharma Dividend Opportunities With Large Margins Of SafetySeeking Alpha • 06/05/19
Bristol-Myers Squibb (BMY) Stock Moves -1.11%: What You Should KnowZacks Investment Research • 05/31/19
Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To SidelinesBenzinga • 05/20/19
This Biotech Stock Is Flying As Cancer Update, Opioid Approval LoomInvestors Business Daily • 05/09/19
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/25/19